openPR Logo
Press release

Stratablue.ai helps RCM firms deliver faster payments and better patient financial experiences

10-20-2025 04:38 PM CET | Health & Medicine

Press release from: ABNewswire

"RCM firms need reliable throughput," added Vidomanets. "We ship fast, measure every step, and tune workflows weekly with the client team. The playbook scales from single-facility groups to large health systems."

"RCM firms need reliable throughput," added Vidomanets. "We ship fast, measure every step, and tune workflows weekly with the client team. The playbook scales from single-facility groups to large health systems."

AI voice agents and automated workflows drive fewer denials, shorter A/R, and higher self-pay collection for hospital partners
Indianapolis, IN - October 20, 2025 - Stratablue.ai announced new AI-driven solutions for revenue cycle management firms serving hospitals nationwide. Teams deploy AI voice agents, automated intake, and CRM-connected workflows to streamline pre-service, mid-cycle, and back-end operations. The result is faster payment, fewer manual touches, and clear communication for patients.

"Our mission is simple. Help RCM partners remove friction from every patient and payer interaction," said Slava Vidomanets, Managing Partner at Stratablue.ai. "AI voice agents handle high-volume calls, while automations keep data clean and tasks on time. Staff focus on the hard problems. Patients get clear, fast answers."

What Stratablue.ai delivers:

- AI voice agents for insurance verification, balance reminders, payment plans, and appointment follow-ups
- Prior authorization and eligibility checks with smart queueing and escalation rules
- Denial prevention and work queues with automated root-cause tagging and next-best actions
- Patient financial engagement with plain-language scripts and personalized payment options
- CRM and EHR integrations using FHIR and HL7 interfaces, plus event-based triggers
- Compliance guardrails including HIPAA alignment, audit trails, and role-based access
- Live dashboards tracking A/R days, first-pass yield, write-offs, call containment, and CSAT

How RCM teams use it:

- Intake: verify coverage, confirm demographics, and flag risks before service
- Mid-cycle: route prior auth requests, alert staff when payers need extra documentation, and log every touch
- Back-end: match remit data to claims, prioritize follow-up by likelihood to pay, and automate patient outreach at the right time

Why it work:

- 24/7 AI voice coverage reduces hold times and call abandonment
- Structured data sync with EHR and CRM eliminates duplicate entry
- Consistent scripts raise first-pass accuracy and reduce avoidable denials
- Real-time alerts keep leaders ahead of SLA risks

Availability Stratablue.ai solutions are live with RCM partners across multiple regions. Implementations follow a phased plan: discovery, workflow design, integrations, pilot, and full roll-out. Typical pilots launch in weeks depending on data access and interface readiness.

About Stratablue.ai

Stratablue.ai builds AI voice agents and automations for sales, service, and healthcare revenue cycle operations. The team designs workflows, integrates with leading EHR and CRM platforms, and provides ongoing optimization to hit collection, cost, and satisfaction targets.

Media Contact
Company Name: StrataBlue
Contact Person: Press
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=stratablueai-helps-rcm-firms-deliver-faster-payments-and-better-patient-financial-experiences]
Phone: 317-207-0195
Address:238 s. Meridian St Suite 201
City: Indianapolis
State: IN
Country: United States
Website: https://stratablue.ai

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Stratablue.ai helps RCM firms deliver faster payments and better patient financial experiences here

News-ID: 4231460 • Views:

More Releases from ABNewswire

Endometriosis Market Trends Point to Steady Growth Ahead by 2034, DelveInsight Analysis Reveals | Ferring Pharma, AbbVie, Myovant, Pfizer, AbbVie, Neurocrine Biosciences, ObsEva, Kissei Pharma
Endometriosis Market Trends Point to Steady Growth Ahead by 2034, DelveInsight A …
The Key Endometriosis Companies in the market include - AbbVie, Myovant, Pfizer, AbbVie, Neurocrine Biosciences, ObsEva, Kissei Pharmaceuticals, Enteris BioPharma Inc., Spago Nanomedical AB, Iqvia Pty Ltd, Nanjing Chia-tai Tianqing Pharmaceutical, Myovant Sciences GmbH, Hope Medicine (Nanjing) Co., Ltd, Ferring Pharmaceuticals, Jiangsu HengRui Medicine, ObsEva, AbbVie, ASKA Pharmaceutical Co., Ltd., Abbott, Kissei Pharmaceutical Co., Ltd., Bayer, Pfizer, and others. DelveInsight's "Endometriosis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth
Southeast Asia Used Construction Equipment Market to Reach USD 2.39 Billion by 2030: Indonesia, Vietnam & Philippines Lead Expansion Fueled by 4.5-5% GDP Growth | Arizton
Southeast Asia Used Construction Equipment Market to Reach USD 2.39 Billion by 2 …
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2025-2030. Southeast Asia is witnessing a powerful resurgence in construction and mining activities, propelling demand for affordable, high-performance used machinery. According to Arizton research, the Southeast Asia used construction equipment market [https://www.arizton.com/market-reports/southeast-asia-used-construction-equipment-market] is valued at USD 1.83 billion in 2024 and is set to climb to USD 2.39 billion by 2030, expanding at a CAGR of 4.54%.
EGFR Inhibitor Market Expected to Gain Momentum Through 2034, According to DelveInsight | Merus, Cullinan Oncology, Taiho Pharma, Suzhou Puhe Pharma, TWi Biotech
EGFR Inhibitor Market Expected to Gain Momentum Through 2034, According to Delve …
The Key EGFR Inhibitor Companies in the market include - Merus, Cullinan Oncology/Taiho Pharma, Suzhou Puhe Pharmaceutical, TWi Biotechnology, and others. DelveInsight's "EGFR Inhibitor Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the EGFR Inhibitor, historical and forecasted epidemiology as well as the EGFR Inhibitor market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the EGFR
How to Fight Food Waste in Canada: Lessons from Ugly Potato Day
10-20-2025 | Arts & Culture
ABNewswire
How to Fight Food Waste in Canada: Lessons from Ugly Potato Day
Over 490,000 pounds of food were saved from waste this year. See how to turn food waste into hope. Cloverdale, BC - October 20, 2025 - Food waste is one of the biggest challenges facing Canada today. Every year, millions of pounds of perfectly edible food end up in landfills, often because of strict cosmetic standards or poor storage habits at home. Not only does this waste contribute to greenhouse gas

All 5 Releases


More Releases for RCM

RCM Matter, a TechMatter Company, Introduces Next-Gen Medical Billing & RCM Soft …
GLENDALE, CA, UNITED STATES, August 27, 2025 -- RCM Matter, a subsidiary of TechMatter, announced the launch of its flagship product, a next-generation Medical Billing and Revenue Cycle Management (RCM) software solution that's built for modern-day healthcare practices. The platform empowers providers with automation, compliance, and transparency, helping them reduce administrative stress and strengthen financial performance. Built from the ground up with healthcare teams in mind, the RCM software offers
Healthcare RCM Outsourcing Market Report 2024 - RCM Outsourcing Market Trends, S …
"The Business Research Company recently released a comprehensive report on the Global Healthcare RCM Outsourcing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive
Investigation announced for Investors in R1 RCM Inc. (NASDAQ: RCM) over potentia …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at R1 RCM Inc. Investors who purchased shares of R1 RCM Inc. (NASDAQ: RCM) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain R1 RCM Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. Murray,
Investigation announced for Investors who lost money with shares of R1 RCM Inc. …
An investigation was announced over potential securities laws violations by R1 RCM Inc. in connection with certain financial statements. Investors who purchased shares of R1 RCM Inc. (NASDAQ: RCM), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of R1 RCM Inc. (NASDAQ: RCM) concerning whether a
Investigation announced for Investors in R1 RCM Inc. (NASDAQ: RCM) over potentia …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at R1 RCM Inc. Investors who purchased shares of R1 RCM Inc. (NASDAQ: RCM) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain R1 RCM Inc. directors breached their fiduciary duties and caused damage to the company and its
Investigation announced for Investors in shares of R1 RCM Inc. (NASDAQ: RCM)
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at R1 RCM Inc. Investors who purchased shares of R1 RCM Inc. (NASDAQ: RCM) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain R1 RCM Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. Chicago,